Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
TRIAZINE DERIVATIVES AS P2X3 AND/OR P2X2/3 RECEPTOR ANTAGONISTS AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
No-Receipt date
2014-01772 - 17/06/2014
No-Filing date
20140401160 - 17/06/2014
No-Granting date
3083647 - 23/06/2014
No-EPO application date
10741243.9 - 10/02/2010
No-EPO granting date
2399910 - 02/04/2014
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
6/2014 - 18/07/2014
Expiration date
11/02/2030
Kind of title
Validation of European Patent
Legal status
NOT VALID
Priorities
JP200903152013/02/2009/JP
JP200926690325/11/2009/JP
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
C07D 401/12
C07D 401/06
C07D 251/52
C07D 251/46
A61P 29/00
A61P 25/08
A61P 25/06
A61P 25/02
A61P 21/00
A61P 13/10
A61P 13/08
A61K 31/5377
A61K 31/53
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
535157
SHIONOGI & CO., LTD.
1-8, DOSHOMACHI 3-CHOME CHUO-KU OSAKA-SHI
OSAKA 541-0045
JAPAN
Inventors
Code
Firstname
Surname
1286392
KAI, HIROYUKI
1286393
KAMEYAMA, TAKAYUKI
1286394
HASEGAWA, TSUYOSHI
1286395
OOHARA, MIHO
1286396
TADA, YUKIO
1286397
ENDOH, TAKESHI
Representatives
Code
Firstname
Surname
Address
Town
Zip
2623
IOANNA
MPANTEKA
VYZANTIOU 12
NEA SMYRNI (ATTIKIS)
17121
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
3054
ANDREAS
MAROULIS
EFESSOU 15
NEA SMYRNI (ATTIKIS)
17121
GREECE
Owners History
Title Instruments
Date
Operation
Descreption
9/4/2018 12:00:00 AM
Έκπτωση Κύριων Τίτλων (79602)
ΕΚΠΤΩΣΕΙΣ 08/2018 Αρ. Πρωτ. ΓΔ 1975 / 04-09-2018
Payments history
8 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).